05.29.2009 | Investors

Watson to Present at the UBS Global Specialty Pharmaceuticals Conference 2009

CORONA, CA, May 29, 2009 (MARKETWIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Mark Durand, Watson's senior vice president and chief financial officer, will provide an overview and update of the Company's business at the UBS Global Specialty Pharmaceuticals Conference 2009 on Wednesday, June 3, 2009 at 1:30 p.m. London Daylight Saving Time (DST) (8:30 a.m. EDT).

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL:


An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Watson Pharmaceuticals, Inc.
Patty Eisenhaur
(951) 493-5611

SOURCE: Watson Pharmaceuticals

Media Contacts
Lisa Brown
Global Corporate Media Relations
+1 (862) 261 7320
Fran DeSena
U.S. Product Media Relations
+1 (201) 427-8762
Janet Kettels
International Product Media Relations
+44 773 850 6476

For local media contacts in other countries, please visit the relevant country website.

Investor relations:

Karina Calzadilla
Investor Relations
+1 (862) 261 7488